Quotes 5-day view Delayed Nasdaq
06/29/2022
06/30/2022
07/01/2022
07/05/2022
07/06/2022
Date
141.98(c)
149.1(c)
157.5(c)
161.03(c)
156.87
Last
1 054 370
2 495 583
1 335 180
1 651 658
433 276
Volume
+1.54%
+5.01%
+5.63%
+2.24%
-2.58%
Change
Estimated financial data (e) EUR USD GBP
Sales 2022
16 835 M
17 247 M
14 487 M
Net income 2022
9 580 M
9 814 M
8 244 M
Net cash position 2022
16 333 M
16 733 M
14 055 M
P/E ratio 2022
4,31x
Yield 2022
-
Sales 2023
9 722 M
9 960 M
8 366 M
Net income 2023
4 926 M
5 047 M
4 239 M
Net cash position 2023
25 147 M
25 762 M
21 639 M
P/E ratio 2023
8,49x
Yield 2023
-
Capitalization
38 198 M
39 133 M
32 870 M
EV / Sales 2022
1,30x
EV / Sales 2023
1,34x
Nbr of Employees
3 082
Free-Float
87,3%
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer...
All news about BIONTECH SE
News in other languages on BIONTECH SE
11:12a BIONTECH : la pharma attaquée en justice par CureVac
10:49a BIONTECH, UNILEVER, JPMORGAN EN JUST : Planète Bourse du 6 juillet
08:03a L'équation se complique à nouveau
07:35a EN DIRECT DES MARCHES : Schneider, Alstom, EDF, GTT, ASML, BYD, Uniper, Albioma, Holcim...
07/05 MÄRKTE USA/Turbulenter Wochenstart - Ölpreise brechen ein
Analyst Recommendations on BIONTECH SE
Zoom Video Communications, Inc.: An attempt to reconnect
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BIONTECH SE
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
157,18 €
Average target price
227,67 €
Spread / Average Target
44,8%
Please enable JavaScript in your browser's settings to use dynamic charts.